In this Trending News Europe episode, Jack, Jen, and Ollie discuss a few recent newsworthy items, including an increase in cyberattacks on the healthcare sector, Europe’s plan to future-proof its Biotech Sector and New Research from the University of Oxford into psilocybin as a potential treatment for depression.
Podcast Tags: healthcare, healthcare news, life sciences, NHS, cybersecurity, biotech, research & development, pharmaceuticals, depression, psilocybin, mental health, psychedelics, mental health awareness week
Source Links:
- ’Large volume’ of data stolen from NHS Dumfries and Galloway published on dark web
- Huge volume of NHS patient and staff data released by hacker
- NHS cyber attack: Why stolen medical information is so much more valuable than financial data
- Cyber attacks are one of the biggest threats facing healthcare systems
- Government Launches NHS Cyber Security Strategy
- US tech group Palantir wins lucrative NHS data contract
- Patient privacy fears as US spy tech firm Palantir wins £330m NHS contract
- European Commission lays down path to future-proof EU biotechnology
- Roche to buy Carmot for up to $3.1bn as race for obesity drugs intensifies
- Roche agrees $7.1bn deal for Telavant to boost drug pipeline
- Europe’s biotech innovation in the balance
- Commission takes action to boost biotechnology and biomanufacturing in the EU
- Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis
- EU launches landmark €6.5M study on use of psychedelics to treat mental disorders
- Magic mushrooms’ psilocybin can alleviate severe depression when used with therapy
- Psychedelic drug research held back by UK rules and attitudes, say scientists
- King’s College Psychoactive Trials Group
Panel – Jack Young, Jen Burke, Ollie May
Research & Production – Karan Pandya, Jack Young
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.